A P rospective rA ndomized tR ial A ssessing the safety and effectiveness of the D urAVR® bI omimetic valve designed for physioloG ic ...
DurAVR ® THV delivered a favorable hemodynamic profile sustained to one-year, with an EOA of 2.1 + 0.2 cm 2 and a mean pressure gradient (MPG) of 8.6 + 2.6 mmHg. At one-year, clinical safety outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback